FDA Adverse Event Malfunction Summary report: N

COBAS C 303 ANALYTICAL UNIT

MDR report key: 23041633 · Received September 12, 2025

Report

Report Number
1823260-2025-02866
Event Type
Malfunction
Date Received
September 12, 2025
Date of Event
August 25, 2025
Report Date
October 10, 2025
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
UDI-DI
07613336220153
PMA / PMN Number
K220134
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TN, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE CALCIUM REAGENT LOT NUMBER WAS 861168. THE REAGENT EXPIRATION DATE WAS REQUESTED, BUT NOT PROVIDED. THE INVESTIGATION IS ONGOING.

Additional Manufacturer Narrative · 0

CALIBRATION AND CONTROLS WERE ACCEPTABLE. THERE WAS NO INDICATION OF A REAGENT PERFORMANCE ISSUE. A REVIEW OF ALARM TRACE DATA SHOWED MULTIPLE ABNORMAL ASPIRATION ALARMS NEAR THE TIME OF THE EVENT. THE FIELD SERVICE ENGINEER DETERMINED THAT THERE WAS AN ISSUE WITH THE REAGENT PACK; THE CUSTOMER STATED THAT SOME OF THE REAGENTS COULD HAVE BEEN LEFT ON THE DOCK AND NOT STORED CORRECTLY. THE CUSTOMER HAD ALSO USED THE INCORRECT CALIBRATOR LOT FOR CALIBRATION. THE REAGENT PACK WAS REPLACED, AND THE INFORMATION FOR THE CORRECT CALIBRATOR LOT WAS DOWNLOADED ONTO THE ANALYZER. CALIBRATION, CONTROLS, AND PRECISION STUDIES WERE PERFORMED WITH NO ISSUES. THE INVESTIGATION DETERMINED THAT THE SERVICE ACTIONS RESOLVED THE ISSUE.

Description of Event or Problem · 0

THE INITIAL REPORTER STATED THEY RECEIVED DISCREPANT RESULTS FOR ONE PATIENT SAMPLE TESTED WITH CALCIUM GEN.2 ON A COBAS C 303 ANALYTICAL UNIT. THE SAMPLE INITIALLY RESULTED IN A CALCIUM VALUE OF 2.1 MG/DL. SINCE THE VALUE WAS A CRITICAL LOW RESULT, THE SAMPLE WAS REPEATED. THE REPEAT RESULT WAS 10.1 MG/DL AND THIS VALUE WAS DEEMED CORRECT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2534760 COBAS C 303 ANALYTICAL UNIT CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS 07613336220153

Patients

Seq Age Sex Outcome Treatment
1 2 MO Female